TGA updates montelukast safety information Extra information is being added to all products to highlight the existing warnings, as a ‘reminder to watch out’ for side effects.
Japanese encephalitis virus spreads to new areas With the virus detected in NSW and Victoria and the season’s first human case, GPs should be prepared for patients asking about protection.
Should Australia be worried about HMPV? As cases of human metapneumovirus surge overseas, what do Australian GPs need to know when concerned patients walk through their door?
New long COVID deep dive A podcast series has revealed new research findings, treatment options, and practical tips for GPs to introduce into their consultations.
Increase in patients turning to AI for therapy As patients face barriers to mental health care, many are turning to ChatGPT for help, but experts say it brings a risk of devastating mistakes.
Study compares Mounjaro to Wegovy for weight loss A new clinical trial, sponsored by the manufacturer, found Mounjaro led to greater weight loss, but GPs warn of its ‘risks of biases’.
GLP-1 receptor agonists linked to kidney failure prevention: Study It found the diabetes and weight-loss drugs can reduce deterioration regardless of diabetes status, but supply remains an issue.
Hypertension costing Australia $1.2 billion a year Researchers are calling for overhauled policies to reduce treatment costs and increase care access, with pharmacy fees making up 51% of spending.
Embedding Aboriginal and Torres Strait Islander values in GP training A first-of-its-kind training framework aims to ensure clinical education is framed by perspectives of Aboriginal and Torres Strait Islander peoples.
Gabapentinoids may increase hip fractures: Study It found patients had 30% increased odds of suffering a hip fracture within two months of taking a gabapentinoid medication.